21 results
S-3ASR
EX-1.2
ALT
Altimmune Inc
28 Feb 23
Automatic shelf registration
4:50pm
8-K
EX-1.1
ALT
Altimmune Inc
25 Feb 21
Entry into a Material Definitive Agreement
4:06pm
8-K
EX-1.1
ALT
Altimmune Inc
16 Jul 20
Altimmune Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
4:38pm
8-K
EX-1.1
ALT
Altimmune Inc
27 Mar 20
Entry into a Material Definitive Agreement
4:08pm
8-K
EX-1.1
ALT
Altimmune Inc
11 Mar 19
Altimmune Announces $14 million Registered Direct Offering
8:45am
8-K
EX-1.1
vhql2 1tn9u56kah
9 Oct 18
Altimmune Announces $25 million Registered Direct Offering
9:14am
8-K
EX-1.1
2534 vh3o2xljf
25 Sep 18
Altimmune Announces $4.9 million Registered Direct Offering of Common Stock
6:06am
8-K
EX-1.1
u1aj 925g0b8wf
17 Aug 17
Altimmune Announces $14.7 Million Series B Preferred Stock Offering
12:00am
8-K
EX-1.1
vp80g7w 5cg6h3rc
10 Jun 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.2
9kysc
1 Nov 10
PharmAthene Announces Proposed Common Stock Public Offering
12:00am
8-K
EX-1.1
uhw4k78gmr 9xj
1 Nov 10
PharmAthene Announces Proposed Common Stock Public Offering
12:00am
8-K
EX-1.1
womlt9a9985sze8fb9g9
20 Jul 10
Pharmathene Announces $3.9 Million Registered Direct Offering
12:00am
8-K
EX-1.1
vkp9k
8 Apr 10
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
vuskxx5
27 Mar 09
Pharmathene Announces $5.5 Million Public Equity Offering
12:00am
8-K
EX-1.2
we8ibqoz9vsycy5yy
27 Mar 09
Pharmathene Announces $5.5 Million Public Equity Offering
12:00am
10-K
EX-1.1.2
zg3x5
31 Mar 06
Annual report
12:00am